|
Improve Compliance: |
| |
No diet or drug restrictions
Safe, non-invasive
CLIA waived with clear readable test results
When it comes to screening for colorectal cancer everyone deserves the E.A.S.Y choice.
E ffective- Hemoccult has been clinically proven to significantly lower the burden of colorectal cancer by reducing incidence and mortality.1,2
A ccessible- Designed to screen large populations of people. Cost effective and samples can be collected at the patient's home.
S afe- Non-invasive.
Y early- Recognized as an effective CRC screening tool when performed on a yearly basis.
Hemoccult ICT is the most clinically proven immunochemical FOBT with high sensitivity and specificity.3
Immunochemical FOBTs, like Hemoccult ICT, are now part of the new standard of care for colorectal cancer screening.4
So do right by your patients and your practice. Hemoccult ICT - do it for life the E.A.S.Y. way.
|
Order No. SK-395065
Qty: 100
CPT*: G0328QW Colorectal Cancer (screening with immunochemical FOBT)
82274QW (Blood, occult, by fecal hemoglobin determination with immunochemical
FOBT)
-Average reimbursement rate - 17.50 - 22.00.test
-BECK395065 100 collection cards 76.80
-Reimbursement shown indicates National Average
CLIA: FDA Cleared/CLIAwaived
Contact: (888)-882-7739
* It is always the provider's responsibility to establish appropriate coding & charges.
|